Sweden's Aplex Bio Gearing up to Launch 'Hyperplexed' PCR Platform
Aplex Bio believes its technology has the sensitivity, specificity, and scale to challenge both digital PCR and next-generation sequencing-based applications.
Stay updated with breaking news from Single Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aplex Bio believes its technology has the sensitivity, specificity, and scale to challenge both digital PCR and next-generation sequencing-based applications.
December 21, 2020 December 21, 2020 | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more. $170M: Israeli ‘Digital Health First’ VC Firm OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spea...